142 related articles for article (PubMed ID: 12642867)
41. Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior.
Tang JZ; Zuo ZH; Kong XJ; Steiner M; Yin Z; Perry JK; Zhu T; Liu DX; Lobie PE
Endocrinology; 2010 Jan; 151(1):43-55. PubMed ID: 19966185
[TBL] [Abstract][Full Text] [Related]
42. Adenovirus-directed expression of dominant negative estrogen receptor induces apoptosis in breast cancer cells and regression of tumors in nude mice.
Lee EJ; Jakacka M; Duan WR; Chien PY; Martinson F; Gehm BD; Jameson JL
Mol Med; 2001 Nov; 7(11):773-82. PubMed ID: 11788792
[TBL] [Abstract][Full Text] [Related]
43. Anti-apoptotic role of STAT5 in haematopoietic cells and in the pathogenesis of malignancies.
Debierre-Grockiego F
Apoptosis; 2004 Nov; 9(6):717-28. PubMed ID: 15505414
[TBL] [Abstract][Full Text] [Related]
44. The influence of STAT5 antisense oligonucleotides on the proliferation and apoptosis of selected human leukaemic cell lines.
Baśkiewicz-Masiuk M; Masiuk M; Machaliński B
Cell Prolif; 2003 Oct; 36(5):265-78. PubMed ID: 14521520
[TBL] [Abstract][Full Text] [Related]
45. Roscovitine inhibits STAT5 activity and induces apoptosis in the human leukemia virus type 1-transformed cell line MT-2.
Mohapatra S; Chu B; Wei S; Djeu J; Epling-Burnette PK; Loughran T; Jove R; Pledger WJ
Cancer Res; 2003 Dec; 63(23):8523-30. PubMed ID: 14679020
[TBL] [Abstract][Full Text] [Related]
46. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H
Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477
[TBL] [Abstract][Full Text] [Related]
47. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone.
Williams CC; Allison JG; Vidal GA; Burow ME; Beckman BS; Marrero L; Jones FE
J Cell Biol; 2004 Nov; 167(3):469-78. PubMed ID: 15534001
[TBL] [Abstract][Full Text] [Related]
48. Specific inhibition of Stat5a/b promotes apoptosis of IL-2-responsive primary and tumor-derived lymphoid cells.
Behbod F; Nagy ZS; Stepkowski SM; Karras J; Johnson CR; Jarvis WD; Kirken RA
J Immunol; 2003 Oct; 171(8):3919-27. PubMed ID: 14530308
[TBL] [Abstract][Full Text] [Related]
49. Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells.
Sultan AS; Xie J; LeBaron MJ; Ealley EL; Nevalainen MT; Rui H
Oncogene; 2005 Jan; 24(5):746-60. PubMed ID: 15592524
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells.
Ahonen TJ; Xie J; LeBaron MJ; Zhu J; Nurmi M; Alanen K; Rui H; Nevalainen MT
J Biol Chem; 2003 Jul; 278(29):27287-92. PubMed ID: 12719422
[TBL] [Abstract][Full Text] [Related]
51. Interactions in the transcriptional regulation exerted by Stat5 and by members of the steroid hormone receptor family.
Stoecklin E; Wissler M; Schaetzle D; Pfitzner E; Groner B
J Steroid Biochem Mol Biol; 1999; 69(1-6):195-204. PubMed ID: 10418993
[TBL] [Abstract][Full Text] [Related]
52. Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers.
Cotarla I; Ren S; Zhang Y; Gehan E; Singh B; Furth PA
Int J Cancer; 2004 Feb; 108(5):665-71. PubMed ID: 14696092
[TBL] [Abstract][Full Text] [Related]
53. Positive selection of apoptosis-resistant cells correlates with activation of dominant-negative STAT5.
Bovolenta C; Testolin L; Benussi L; Lievens PM; Liboi E
J Biol Chem; 1998 Aug; 273(33):20779-84. PubMed ID: 9694822
[TBL] [Abstract][Full Text] [Related]
54. Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice.
Iavnilovitch E; Cardiff RD; Groner B; Barash I
Int J Cancer; 2004 Nov; 112(4):607-19. PubMed ID: 15382041
[TBL] [Abstract][Full Text] [Related]
55. Dominant negative ER induces apoptosis in GH(4) pituitary lactotrope cells and inhibits tumor growth in nude mice.
Lee EJ; Duan WR; Jakacka M; Gehm BD; Jameson JL
Endocrinology; 2001 Sep; 142(9):3756-63. PubMed ID: 11517151
[TBL] [Abstract][Full Text] [Related]
56. The structure of human STAT5A and B genes reveals two regions of nearly identical sequence and an alternative tissue specific STAT5B promoter.
Ambrosio R; Fimiani G; Monfregola J; Sanzari E; De Felice N; Salerno MC; Pignata C; D'Urso M; Ursini MV
Gene; 2002 Feb; 285(1-2):311-8. PubMed ID: 12039059
[TBL] [Abstract][Full Text] [Related]
57. Reconstitution of estrogen-dependent transcriptional activation of an adenoviral target gene in select regions of the rat mammary gland.
Jeng MH; Kao C; Sivaraman L; Krnacik S; Chung LW; Medina D; Conneely OM; O'Malley BW
Endocrinology; 1998 Jun; 139(6):2916-25. PubMed ID: 9607802
[TBL] [Abstract][Full Text] [Related]
58. Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development.
Bromberg J
Breast Cancer Res; 2000; 2(2):86-90. PubMed ID: 11250696
[TBL] [Abstract][Full Text] [Related]
59. Stat5 in breast cancer: potential oncogenic activity coincides with positive prognosis for the disease.
Barash I
Carcinogenesis; 2012 Dec; 33(12):2320-5. PubMed ID: 23161573
[TBL] [Abstract][Full Text] [Related]
60. Toward gene therapy of endometriosis: adenovirus-mediated delivery of dominant negative estrogen receptor genes inhibits cell proliferation, reduces cytokine production, and induces apoptosis of endometriotic cells.
Othman EE; Salama S; Ismail N; Al-Hendy A
Fertil Steril; 2007 Aug; 88(2):462-71. PubMed ID: 17343855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
